期刊文献+

全脑放疗联合替莫唑胺治疗非小细胞肺癌脑转移的荟萃分析 被引量:24

Whole brain radiation therapy plus temozolomide in the treatment of brain metastases from nonsmall cell lung cancer: a meta-analysis
原文传递
导出
摘要 目的通过荟萃分析,探讨全脑放疗(WBRT)联合替莫唑胺(TMZ)治疗非小细胞肺癌(NSCLC)脑转移的疗效及安全性。方法通过Medline、EMBASE、Cochrane、CBM等数据库检索国内外文献截止日期为2011年12月31日相关文献。选择治疗组为WBRT+TMZ、对照组为单纯WBRT的NSCLC脑转移的随机对照试验(RCT)。由2位评价者分别按上述检索策略收集资料,按纳人标准人选,主要对客观缓解及不良反应进行荟萃分析,其次是总生存(OS)。结果共纳人4个RCT。WBRT+TMZ与单纯WBRT相比,前者客观缓解率是后者的1.55倍(P=0.003);在不良反应方面,胃肠道不良反应(恶心、呕吐)的发生率两组相当(P=0.14),而血液学不良反应(3/4度骨髓抑制)的发生率前者是后者的2.47倍(P=0.008);在远期疗效方面,两组间生存获益的可能性相当(P=0.69)。结论现有证据提示对于NSCLC脑转移的治疗,WBRT+TMZ与单纯WBRT相比,改善了客观缓解,但增加了血液学不良反应,未能将近期的局控获益转化为远期的生存获益。因此,对于WBRT+TMZ治疗NSCLC脑转移的疗效和安全性,还需要进一步的大规模、高质量、前瞻性的Ⅲ期临床研究进行验证。 Objective To explore the efficacy and safety of whole brain radiation therapy (WBRT) plus temozolomide (TMZ) versus WBRT alone in the treatment of brain metastases from non-small cell lung cancer (NSCLC) through a meta-analysis. Methods All previously published and some unpublished studies were comprehensively searched from the databases of MEDLINE, EMBASE, Coehrane Library and CBM, etc. The meta-analysis included all randomized controlled trials (RCTs) to compare WBRT plus TMZ with WBRT alone in treatment of brain metastases from NSCLC. The primary meta-analysis was based upon objective remission (OR) and toxicity and the second overall survival (OS). Results Four RCTs identified by two reviewers were included. There was significant improvement for the WBRT + TMZ group in OR rate ( RR = 1.55, P = 0. 003 ) ; but without significant improvement in OS ( P = 0. 69). Meanwhile, WHO grade Ⅲ/Ⅳ hematologic toxicity of myelosuppression increased in the WBRT + TMZ group ( RR = 2.47, P = 0. 008), but without significant difference in gastrointestinal toxicity ( P = 0. 14 ). Conclusions For the treatment of brain metastases from NSCLC, the combined therapy of WBRT plus TMZ improves OR, but without significant improvement in OS. And the incidence of myelosuppression is elevated. Future large- scale, high-quality and prospective phaseⅢ RCTs are needed to confirm the clinical efficacy and safety of WBRT olus TMZ.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第45期3199-3203,共5页 National Medical Journal of China
关键词 非小细胞肺 肿瘤转移 放射疗法 计算机辅助 Carcinoma, non-small-cell lung Neoplasm metastasis Radiotherapy, computer- assisted
  • 相关文献

参考文献13

  • 1Hutter A, Schwetye KE, Bierhals A J, et al. Brain neoplasms:epidemiology, diagnosis, and prospects for cost-effective imaging. Neuroimaging Clin N Am,2003,13:237-250.
  • 2Wen PY, Loeffler JS. Management of brain metastases. Oncology ( Williston Park), 1999,13 : 941-954,957 -961.
  • 3Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist ,2007,12:884-898.
  • 4Liu R, Wang X, Ma B, et al. Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis. Anticaneer Drugs ,2010,21 : 120-128.
  • 5Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996,17 : 1-12.
  • 6Chua D, Krzakowski M, Chouaid C, et al. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open- label phase l/ study. Clin Lung Cancer,2010,11 : 176-181.
  • 7Antonadou D, Coliarakis N, Paraskevaidis M, et al. A multi- institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus radiotherapy alone. Lung Cancer, 2003,41 Supp/2 : S22-S23.
  • 8周蕾,安广宇,岳振东,陈力,宋雨光,姜妮.替莫唑胺联合放疗在非小细胞肺癌脑转移中的临床研究[J].中国药房,2011,22(22):2072-2074. 被引量:21
  • 9谢家印,向德兵,王阁,杨镇洲,李毅,余娴,罗唯,王东.替莫唑胺联合全脑放疗治疗非小细胞肺癌脑转移临床研究[J].重庆医学,2007,36(19):1941-1942. 被引量:20
  • 10Vermeulen SS. Whole brain radiotherapy in the treatment of metastatic brain tumors. Semin Surg Oncol, 1998,14:64-69.

二级参考文献16

  • 1AndrewsDW ScottCB SperdutoPW FlandersAE GasparLE SchellMC Werner-WasikM DemasW RyuJ BaharyJP SouhamiL RotmanM MehtaMP CurranWJJr.Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase Ⅲ resuIts of the RTOG 9508 randomised trial[J].中国神经肿瘤杂志,2004,2(3):192-192. 被引量:215
  • 2Eichler AF, Loeffier JS. Multidisciplinary management of brain metastases[J]. Oncologist, 2007,12 (7) : 884.
  • 3Lagerwaard FJ, Levendag PC, Nowak PJ, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients[J]. Int J Radiat Oncol Biol Phys, 1999,43(4) :795.
  • 4Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treatd with concomitant radiation plus temozolomide followed by adjuvant temozolomide[J]. J Clin Oncol,2002,20(5) : 1 375.
  • 5Postmus PE, Haaxma-Reiche H, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy-- a phase IU study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group[J]. J Clin Oncol, 2000,18( 19 ) : 3 400.
  • 6Fujita A, Fukuoka S, Takabatake H, et al.Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer[J].Oncology, 2000,59 (4) : 291.
  • 7Stupp R, Newlands E.New approaches for temozolomide therapy: use in newly diagnosed glioma[J]. Semin Oncol, 2001,28(4 Suppl 13) 19.
  • 8Rodrigus P, de Brouwer P, Raaymakers E. Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation[J]. Lung Cancer,2001,32(2) : 129.
  • 9黄莹,张少军,李盈.治疗非小细胞肺癌的新药——吉非替尼[J].中国药房,2007,18(28):2219-2220. 被引量:5
  • 10Higgins JPT,Green S,editors.Cochrane Handbook for Systematic Reviews of Interventions 4.2.6[updated September 2006].In:The Cochrane Library,Issue 4,2006.Chichester,UK:John Wiley & Sons,Ltd.

共引文献165

同被引文献278

引证文献24

二级引证文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部